TET2 and acute myeloid leukemia: AML-associated mutations in IDH1/2 perturb this function, altering the citric acid cycle, and leading to production of the oncometabolite 2-hydroxyglutarate, which alters DNA methylation via inhibition of ten-eleven translocation 2 (TET2) (70, 71).